CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,333 | 1,334 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −3,333 | 6,667 | ||
| 2024-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2024-01-31 | Kim Dong Chief Financial Officer | Option exercise | +3,333 | 26,585 | ||
| 2024-01-31 | Kim Dong Chief Financial Officer | Option exercise · Restricted Stock Units | −3,333 | 6,667 | ||
| 2024-01-31 | Kim Dong Chief Financial Officer | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2024-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Restricted Stock Units | +87,615 | 87,615 | ||
| 2023-09-07 | Belldegrun Arie Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | Cohen Fred E Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | Wildman Daniel George Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | Holden Stuart Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | Robinson James A. Jr. Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | WEN LEANA Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2023-09-07 | Smith Jason Drew General Counsel | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2023-09-07 | Kim Dong Chief Financial Officer | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2023-09-07 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2023-08-31 | Smith Jason Drew General Counsel | Option exercise | +8,334 | 22,207 | ||
| 2023-08-31 | Smith Jason Drew General Counsel | Sale | −3,800 | $18.01 | $68K | 18,407 |
| 2023-08-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −8,334 | 0 |
Page 9 of 13 · 244 trades